Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control.
Stanik, J
Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control. [electronic resource] - Diabetic medicine : a journal of the British Diabetic Association 03 2018 - 386-391 p. digital
Publication Type: Case Reports; Comparative Study; Research Support, Non-U.S. Gov't; Journal Article
1464-5491
10.1111/dme.13575 doi
Adult
Diabetes Mellitus--blood
Drug Substitution
Drug Therapy, Combination
Female
Glyburide--therapeutic use
Glycated Hemoglobin--metabolism
Humans
Hypoglycemic Agents--therapeutic use
Insulin--therapeutic use
Male
Mutation--genetics
Potassium Channels, Inwardly Rectifying--genetics
Young Adult
Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control. [electronic resource] - Diabetic medicine : a journal of the British Diabetic Association 03 2018 - 386-391 p. digital
Publication Type: Case Reports; Comparative Study; Research Support, Non-U.S. Gov't; Journal Article
1464-5491
10.1111/dme.13575 doi
Adult
Diabetes Mellitus--blood
Drug Substitution
Drug Therapy, Combination
Female
Glyburide--therapeutic use
Glycated Hemoglobin--metabolism
Humans
Hypoglycemic Agents--therapeutic use
Insulin--therapeutic use
Male
Mutation--genetics
Potassium Channels, Inwardly Rectifying--genetics
Young Adult